wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33428645-462A0108-17C3-45E1-82A6-AC53CD1363CD
Q33428645-462A0108-17C3-45E1-82A6-AC53CD1363CD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33428645-462A0108-17C3-45E1-82A6-AC53CD1363CD
Phase 2 trial of neoadjuvant bevacizumab plus pemetrexed and carboplatin in patients with unresectable stage III lung adenocarcinoma (GASTO 1001).
P2860
Q33428645-462A0108-17C3-45E1-82A6-AC53CD1363CD
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33428645-462A0108-17C3-45E1-82A6-AC53CD1363CD
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7523473d836e0061e845ae86c1b578803cb563fb
P2860
Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer.